EV/EBITDA:
-15.08+0.54(+3.46%)Summary
- As of today (September 14, 2025), MLTX EV/EBITDA is -15.08, with a rise of +0.54 (+3.46%) during the most recent trading session on September 12, 2025.
- Over the past year, MLTX EV/EBITDA has increased by +19.30 (+56.14%).
- MLTX EV/EBITDA is now -1336.19% below its all-time high of -1.05.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.5% | -3.4% | -3.1% |
| 1 m1 month | +4.5% | -4.5% | -4.0% |
| 3 m3 months | -6.7% | +25.2% | +19.5% |
| 6 m6 months | -4.7% | +46.5% | +33.9% |
| ytdytd | +28.1% | +0.7% | -2.8% |
| 1 y1 year | +56.1% | +11.1% | +3.1% |
| 5 y5 years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -15.08 | at high | -17.80 | +15.3% |
| 3 m | 3-month | -13.15 | -14.7% | -17.80 | +15.3% |
| 6 m | 6-month | -9.94 | -51.7% | -17.80 | +15.3% |
| 1 y | 1-year | -9.94 | -51.7% | -37.88 | +60.2% |
| 3 y | 3-year | -2.82 | -434.8% | -61.99 | +75.7% |
| 5 y | 5-year | -1.05 | -1336.2% | -1492 | +99.0% |
| alltime | all time | -1.05 | -1336.2% | -1492 | +99.0% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.08(-28.1%) |
| 2024 | -20.96(-63.9%) |
| 2023 | -58.11(+1019.7%) |
| Date | Value |
|---|---|
| 2022 | -5.19(+121.8%) |
| 2021 | -2.34(-99.8%) |
| 2020 | -1333.00 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -15.08
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -1.05
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +5.88 (+28.05%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +19.30 (+56.14%)